The use of the drugs in treating low mood has sparked debate, not least about the necessity of a hallucinogenic experience. But a new discovery may provide an answer
NRx Pharmaceuticals, Inc. (NASDAQ:NRXPW – Get Free Report) was the target of a large decline in short interest in May. As of May 15th, there was short interest totalling 1,400 shares, a decline of 30.0% from the April 30th total of 2,000 shares. Based on an average daily trading volume, of 29,400 shares, the short-interest […]
NRx Pharmaceuticals, Inc. (NASDAQ:NRXPW – Get Free Report) saw a large drop in short interest in the month of May. As of May 15th, there was short interest totalling 1,400 shares, a drop of 30.0% from the April 30th total of 2,000 shares. Based on an average daily volume of 29,400 shares, the days-to-cover ratio […]
Unlike approved antidepressant drugs which have warnings on their labels stating they may increase the suicide risk, NRX-101 demonstrates meaningful reductions in suicidality.